ATP13A2 and Lewy body dementia: In vitro data show that ATP13A2 deficits lead to lysosomal, autophagic and mitochondrial dysfunction and α-synuclein accumulation, which are known features of Lewy body diseases, and that increasing ATP13A2 levels can alleviate α-synuclein toxicity [2, 12, 13].